Analysts Are Recommending Novartis AG (NVS) As A Buy Candidate
Novartis AG (NYSE:NVS) has a beta value of 0.52 and has seen 0.9 million shares traded in the recent trading session. The company, currently valued at $194.89B, closed the recent trade at $81.18 per share which meant it gained $0.42 on the day or 0.52% during that session. The NVS stock price is -16.11% off … Analysts Are Recommending Novartis AG (NVS) As A Buy Candidate Read More »
Analysts Are Recommending Novartis AG (NVS) As A Buy Candidate
Novartis AG (NYSE:NVS) has a beta value of 0.52 and has seen 0.9 million shares traded in the recent trading session. The company, currently valued at $194.89B, closed the recent trade at $81.18 per share which meant it gained $0.42 on the day or 0.52% during that session. The NVS stock price is -16.11% off … Analysts Are Recommending Novartis AG (NVS) As A Buy Candidate Read More »